Are Glutamine (L-Glutamine) Supplements Used in Cancer Treatment?
In this article
Glutamine (L-glutamine)is one of the most abundant free amino acids in the human body, found at particularly high concentrations in muscle, intestinal mucosa, immune cells, and kidney tissue. Normally classified as nonessential—meaning the body can synthesize it—it becomes "conditionally essential" in highly catabolic states such as stress, trauma, infection, or cancer.
Glutamine metabolism is particularly important during cancer treatment: it is a key substrate in cell proliferation and energy metabolism, while supporting mucosal and immune-system recovery from chemotherapy- and radiotherapy-related toxicities. This dual role—potentially supporting tumor growth while protecting normal-tissue repair—makes glutamine a "double-edged sword" in oncology.
Recent studies offer important clues about how and under what conditions glutamine can safely be integrated into clinical practice. This article summarizes its biological function, cancer-related metabolism, supportive-care uses, dosing and side-effect profile , and current scientific evidence.
Glutamine's Biological Role
In cellular metabolism, glutamine acts as a carrier of carbon and nitrogen . It is essential for energy and nucleotide synthesis, particularly in rapidly dividing cells such as intestinal epithelial cells, lymphocytes, and macrophages. It is also a precursor of glutathione, a key component of the antioxidant system.
Glutamine metabolism enables cells to:
- Obtain amino acids for protein synthesis,
- Support immune functions, particularly T-lymphocyte proliferation,
- Maintain intestinal mucosal integrity,
- Regulate acid–base balance through renal ammonium production.
Glutamine Metabolism in Cancer
Many malignant cells consume more glutamine, a phenomenon called "glutamine addiction". Glutamine fuels tumor-cell growth and antioxidant defenses. After entering the cell, it is converted by the enzyme glutaminase (GLS) into glutamate, which then provides carbon for the TCA cycle. This pathway is particularly prominent in cancers with overexpression of the MYC oncogene .
Glutamine metabolism is therefore being studied as a therapeutic target , while its use as a dietary supplement requires caution.
Uses of Glutamine in Oncology
- Oral mucositis: Topical/oral glutamine may be used to reduce mucositis caused by chemotherapy or head-and-neck radiotherapy.
- Radiation enteritis: It may help protect and repair the intestinal mucosa.
- Peripheral neuropathy: Its protective role in neuropathic pain caused by platinum- and taxane-based drugs has been investigated.
- Nutritional support: It may reduce protein breakdown in catabolic states and support immune function.
Scientific Evidence and Limitations
- Glutamine supplementation may reduce mucositis and enteritis scores; however, randomized phase III data are limited.
- Glutamine metabolism differs between tumor cells; some subtypes are sensitive to glutaminase inhibitors, while others are not.
- The risk of accelerating tumor growth is theoretical, with no clear evidence in human studies; cautious use is nevertheless necessary.
Dosing and Administration Protocols
| Use | Dose Range | Administration Method |
|---|---|---|
| Oral mucositis | 5–10 g, 3-6 times daily | "Swish & swallow": hold in the mouth for 1–2 min, then swallow |
| Radiation enteritis | 0.3 g/kg/day (divided doses) | Oral powder or solution with adequate hydration |
| Peripheral neuropathy | 10 g, 2–3 times daily (5–10 days) | During treatment cycles (for example, days 1–10) |
| Nutritional support | 0.2–0.4 g/kg/day | Divided oral doses under dietitian supervision |
Doses are drawn from clinical experience and studies; supplements should not be used without a physician's decision.
Possible Side Effects and Safety Profile
- Generally well tolerated; nausea, gas, headache, or mild diarrhea may occur rarely.
- Because of the risk of hyperammonemia, it is contraindicated in severe liver failure or urea cycle disorders.
- It may accumulate in the blood in kidney failure and should be used cautiously.
- Data during pregnancy and breastfeeding are insufficient; use should follow clinical judgment.
Supportive Use ↔ Therapeutic Approach
- Supportive approach: Aims to reduce treatment-related side effects such as mucositis, enteritis, and neuropathy.
- Therapeutic/metabolic targeting: Inhibiting glutamine metabolism in tumor cells with GLS inhibitors remains investigational.
- Conclusion: Glutamine supplementation is an adjunct to improve tolerability and quality of life, rather than a replacement for treatment.
Examples From the Literature
- MASCC/ISOO guidelines (2024): State that topical glutamine may benefit some cases of oral mucositis; recommendation level "C."
- Head & Neck RT studies: Glutamine has been observed to reduce pain scores and mucositis duration.
- Colorectal RT cases: Data suggest it may reduce stool frequency and fluid loss in radiation-induced enteritis.
- Neuropathy studies: Reduced sensory neuropathy incidence has been reported with paclitaxel- and cisplatin-based regimens (small RCTs).
Clinical Recommendations and Practical Notes
- Glutamine supplementation should be planned with a physician and dietitian .
- Decisions should consider tumor type, stage, treatment plan, and toxicity profile together.
- During use, liver and kidney function tests should be monitored.
- If glutamine is used during active chemotherapy or radiotherapy cycles, current prescribing and patient information (KÜB/KT) should be checked for potential interactions.
- For every patient, the benefit–risk balance should be determined individually.
Glutamine is licensed in Türkiye and available from pharmacies . SGK provides reimbursement for cancer and cachexia diagnoses for this product. Price: Nurimedica glutamine sachet: 602 TL; Resource Glutamin sachet: 907 TL.
References
- Altman BJ, Stine ZE, Dang CV. Role of Glutamine in Cancer – Therapeutic and Imaging Implications. J Exp Med. 2012.
- Amelio I, Cutruzzolá F, Antonov A, et al. Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cell Biol. 2017.
- Choi Y-K, Coloff JL. Targeting Glutamine Metabolism as a Therapeutic Strategy for Cancer. Nat Rev Mol Cell Biol. 2023.
- Andrews NP, et al. Glutamine and Chemotherapy-Induced Toxicity. Support Care Cancer. 2012.
- MASCC/ISOO Clinical Practice Guidelines for Oral and GI Toxicities, 2024.
- Smith A, et al. Glutamine Supplementation in Oncology Supportive Care: Review and Meta-Analysis. Cancers (MDPI) 2025.
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.